EUVIMEDEUVIMED entdecken
Crossref

Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer

Zhen Tang, Ningjing Zhang, Shuang Chen, Jiebin Fang iD, Xinyi Tang, Yijie Lou, Yongjun Jiang, Yijun Ma, Xiaoming Chen, Zhe Chen, Shuai Zhan, Xia Ding und 2 weitere

Journal of Medicinal Chemistry · 08.08.2024 · 67 (15) · 13446-13473

DOI: 10.1021/acs.jmedchem.4c01323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.07.2024. Verfasst von Zhen Tang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Proliferation, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Sanya Yazhou Bay Science and Technology City, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the structure of caerulomycin A, 90 novel bipyridine derivatives were designed and synthesized. Among these, compound B19 exerted strong antitumor effects in vivo and in vitro. Importantly, NOP2/Sun RNA methyltransferase 3 (NSUN3) protein was identified as the target specific binding to B19, which inhibits oxidative phosphorylation of mitochondrial energy metabolism and enhances glycolytic activity by binding to NSUN3. Knockdown of NSUN3 inhibited both proliferation and migration of colorectal cancer (CRC) cells by activating AMPK-related signaling and inhibiting downstream STAT3 signaling to exert antiproliferative and pro-apoptotic effects. Our findings support the use of NSUN3 inhibitors as promising therapeutic strategies against CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCell ProliferationAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorMethyltransferasesApoptosisPyridinesMice, NudeStructure-Activity RelationshipEnzyme InhibitorsMice, Inbred BALB CSTAT3 Transcription FactorCell Movement

Substanzen

Antineoplastic AgentsMethyltransferasesPyridinesEnzyme InhibitorsSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China.
  • Key Laboratory of Digestive Pathophysiology of Zhejiang Province, the First Affiliated Hospital of Zhejiang Chinese Medicine, First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • College of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316021, China.
  • Hainan Institute of Zhejiang University, Sanya 572025, China.

ORCID-Profile: Jiebin Fang, Zhongjun Ma

Förderung

  • Sanya Yazhou Bay Science and Technology City
  • National Natural Science Foundation of China

Zitieren

APA

Tang, Z., Zhang, N., Chen, S., Fang, J., Tang, X., Lou, Y., Jiang, Y., Ma, Y., Chen, X., Chen, Z., Zhan, S., Ding, X., Ding, W., & Ma, Z. (2024). Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of Medicinal Chemistry, 67(15), 13446-13473. https://doi.org/10.1021/acs.jmedchem.4c01323

Vancouver

Tang Z, Zhang N, Chen S, Fang J, Tang X, Lou Y, et al. Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of Medicinal Chemistry. 2024;67(15):13446-13473. doi:10.1021/acs.jmedchem.4c01323

BibTeX
@article{Tang2024,
  author = {Tang, Zhen and Zhang, Ningjing and Chen, Shuang and Fang, Jiebin and Tang, Xinyi and Lou, Yijie and Jiang, Yongjun and Ma, Yijun and Chen, Xiaoming and Chen, Zhe and Zhan, Shuai and Ding, Xia and Ding, Wanjing and Ma, Zhongjun},
  title = {Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {15},
  pages = {13446--13473},
  doi = {10.1021/acs.jmedchem.4c01323}
}
Kostenlos starten →